Neogenomics Inc. (NEO)

전일 마감가:

$14.14

열려 있는:

$14.34

하루 거래량:

307.49K

시가총액:

$1.81B

수익:

$591.64M

순이익/손실:

$-87.97M

주가수익비율:

-19.69

EPS:

-0.77

순현금흐름:

$-30.71M

1주 성능:

+12.97%

1개월 성능:

-3.56%

6개월 성능:

+11.39%

1년 성능:

+3.69%

1일 변동 폭

$14.32

$15.18

52주 변동 폭

$11.03

$21.22

Neogenomics Inc. Stock (NEO) Company Profile

명칭

Neogenomics Inc.

부문

Healthcare (1191)

산업

Diagnostics & Research (66)

전화

239-768-0600

주소

12701 Commonwealth Drive, Suite 9, Fort Myers, FL

직원

1,000

트위터

@NeoGenomics

다음 수익 날짜

2024-05-23

최신 SEC 제출 서류

NEO's Discussions on Twitter

Neogenomics Inc. Stock (NEO) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2023-12-29	재확인	BTIG Research	Buy
2023-08-21	업그레이드	Stephens	Equal-Weight → Overweight
2023-05-16	다운그레이드	Raymond James	Outperform → Mkt Perform
2023-05-09	업그레이드	BTIG Research	Neutral → Buy
2023-02-24	업그레이드	The Benchmark Company	Hold → Buy
2023-02-01	업그레이드	Needham	Hold → Buy
2022-08-26	다운그레이드	The Benchmark Company	Buy → Hold
2022-08-22	다운그레이드	Needham	Buy → Hold
2022-06-03	개시	Piper Sandler	Overweight
2022-03-29	다운그레이드	BofA Securities	Buy → Neutral
2022-03-29	다운그레이드	Stephens	Overweight → Equal-Weight
2022-01-18	재개	Stephens	Overweight
2021-12-16	개시	Cowen	Outperform
2021-11-05	다운그레이드	Morgan Stanley	Overweight → Equal-Weight
2021-10-14	업그레이드	Raymond James	Mkt Perform → Outperform
2021-06-03	개시	Goldman	Buy
2021-02-25	재개	Needham	Buy
2021-02-25	다운그레이드	Raymond James	Outperform → Mkt Perform
2021-01-28	개시	Truist	Buy
2020-12-11	재개	BTIG Research	Buy
2020-10-28	재확인	Needham	Buy
2020-09-09	개시	Morgan Stanley	Overweight
2020-08-28	개시	Guggenheim	Buy
2020-07-29	재확인	Needham	Buy
2020-06-25	개시	BofA/Merrill	Buy
2020-04-21	재개	Stephens	Overweight
2020-03-02	재개	Craig Hallum	Buy
2020-02-28	업그레이드	First Analysis Sec	Outperform → Strong Buy
2020-01-23	다운그레이드	First Analysis Sec	Strong Buy → Outperform
2019-10-30	재확인	Needham	Buy
2019-05-01	재확인	Needham	Buy
2019-03-29	재확인	Needham	Buy
2019-01-03	개시	Needham	Buy
2018-10-24	업그레이드	First Analysis Sec	Outperform → Strong Buy
2018-08-21	개시	Leerink Partners	Outperform
2018-05-02	다운그레이드	First Analysis Sec	Overweight → Equal-Weight
2017-09-11	다운그레이드	BTIG Research	Buy → Neutral
2017-08-24	개시	Gabelli & Co	Buy
2016-12-15	개시	Cantor Fitzgerald	Overweight

모두보기

Neogenomics Inc. 주식(NEO)의 최신 뉴스

Will Myriad Genetics (MYGN) Report Negative Q1 Earnings? What You Should Know

Zacks Investment Research

NeoGenomics (NEO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Zacks Investment Research

Absci Corporation (ABSI) Moves 16.8% Higher: Will This Strength Last?

Zacks Investment Research

Wall Street Breakfast: The Week Ahead

Seeking Alpha

All You Need to Know About NeoGenomics (NEO) Rating Upgrade to Buy

Zacks Investment Research

Does NeoGenomics (NEO) Have the Potential to Rally 43.34% as Wall Street Analysts Expect?

Zacks Investment Research

Neogenomics Inc. (NEO) 재무 분석

Neogenomics Inc. (NEO) 매출 2024

Neogenomics Inc. (NEO) 순이익 2024

Neogenomics Inc. (NEO) 현금흐름 2024

Neogenomics Inc. (NEO) 주당 순이익 2024